Randomized trial of intralesional steroid injection versus oral prednisolone for preventing esophageal stricture after extensive endoscopic submucosal dissection
Diseases of the Esophagus · 02.03.2026 · 39 (2)
DOI: 10.1093/dote/doag027 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Diseases of the Esophagus, online erschienen am 02.04.2026. Verfasst von Joel Fernandez de Oliveira und 7 weiteren Autor:innen. Beteiligte Einrichtung: Serviço de Endoscopia Gastrointestinal, Instituto do Câncer do Estado de São Paulo (ICESP) da Faculdade de Medicina da Universidade de São Paulo (FMU…. Hauptthemen laut MEDLINE: Esophageal Stenosis, Prednisolone, Endoscopic Mucosal Resection, Triamcinolone. Die Arbeit nennt 48 Literaturangaben.
Abstract (Originalsprache)
Endoscopic submucosal dissection (ESD) is the preferred treatment for early esophageal neoplasms. However, ESD involving more than three-quarters of the esophageal circumference often leads to stricture formation. While corticosteroids are widely used to prevent strictures, the optimal route of administration remains unclear. This study aimed to compare submucosal corticosteroid injection (IC) with oral corticosteroid administration (OC) in decreasing the number of dilations required for stricture resolution, stricture rate, and stricture resolution rate. This was a single-center, open-label, randomized clinical trial. Thirty patients with esophageal mucosal defects involving more than three-quarters of the esophageal circumference were enrolled and randomly assigned to two groups. The IC group received 100 mg of triamcinolone injected into the resection bed immediately after the procedure. The OC group was given oral prednisolone starting 3 days post-ESD, initially at 30 mg/day, tapered over 8 weeks. A total of 30 patients were included, 15 in each group. The OC group required significantly fewer dilation sessions than the IC group (5 vs. 19; P = 0.04). However, the stricture rate was similar between the groups (OC: 66.7% vs. IC: 40%; P = 0.27), as well as the stricture resolution rate (OC: 50% vs. IC: 40%; P > 0.99). No significant differences were observed in other adverse events or blood glucose levels between the groups. Oral corticosteroids resulted in fewer dilation sessions to resolve strictures after extensive esophageal ESD compared to intralesional injections. No differences were observed in stricture rates or other adverse events between the two groups. ClinicalTrials.gov (NCT04498260).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Serviço de Endoscopia Gastrointestinal, Instituto do Câncer do Estado de São Paulo (ICESP) da Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, SP, Brazil.
ORCID-Profile: Joel Fernandez de Oliveira, Bruno Costa Martins, Renata Nobre Moura
Zitieren
APA
de Oliveira, J. F., Martins, B. C., Moura, R. N., de Paulo, G. A., Lenz, L., de Lima, M. S., Safatle-Ribeiro, A. V., & Maluf-Filho, F. (2026). Randomized trial of intralesional steroid injection versus oral prednisolone for preventing esophageal stricture after extensive endoscopic submucosal dissection. Diseases of the Esophagus, 39(2). https://doi.org/10.1093/dote/doag027
Vancouver
de Oliveira JF, Martins BC, Moura RN, de Paulo GA, Lenz L, de Lima MS, et al. Randomized trial of intralesional steroid injection versus oral prednisolone for preventing esophageal stricture after extensive endoscopic submucosal dissection. Diseases of the Esophagus. 2026;39(2). doi:10.1093/dote/doag027
BibTeX
@article{deOliveira2026,
author = {de Oliveira, Joel Fernandez and Martins, Bruno Costa and Moura, Renata Nobre and de Paulo, Gustavo Andrade and Lenz, Luciano and de Lima, Marcelo Simas and Safatle-Ribeiro, Adriana Vaz and Maluf-Filho, Fauze},
title = {Randomized trial of intralesional steroid injection versus oral prednisolone for preventing esophageal stricture after extensive endoscopic submucosal dissection},
journal = {Diseases of the Esophagus},
year = {2026},
volume = {39},
number = {2},
doi = {10.1093/dote/doag027}
}
EUVIMED